Unknown

Dataset Information

0

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.

ABSTRACT: The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the "Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents" as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.

SUBMITTER: Mohammed A 

PROVIDER: S-EPMC8749317 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.

Mohammed Altaf A   Dashwood Roderick H RH   Dickinson Sally S   Disis Mary L ML   Jaffee Elizabeth M EM   Johnson Bryon D BD   Khleif Samir N SN   Pollak Michael N MN   Schlom Jeffrey J   Shoemaker Robert H RH   Stanton Sasha E SE   Wondrak Georg T GT   You Ming M   Zhu Hao H   Miller Mark Steven MS  

Journal of cancer prevention 20211201 4

The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the "Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents" as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunopre  ...[more]

Similar Datasets

Unknown Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.
| S-EPMC8020174 | biostudies-literature
Unknown Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.
| S-EPMC4988336 | biostudies-literature
Unknown Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop.
| S-EPMC5006908 | biostudies-literature
Unknown Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report.
| S-EPMC8475065 | biostudies-literature
Unknown Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
| S-EPMC9995163 | biostudies-literature
Unknown Achieving affective human-virtual agent communication by enabling virtual agents to imitate positive expressions.
| S-EPMC7136238 | biostudies-literature
Unknown Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis.
| S-EPMC3971053 | biostudies-literature
Unknown An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.
| S-EPMC5946685 | biostudies-literature
Unknown Emerging Trends in Cancer Prevention Agent Development.
| S-EPMC10080017 | biostudies-literature
Unknown Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.
| S-EPMC3085704 | biostudies-other